Myricetin protects against diet-induced obesity and ameliorates oxidative stress in C57BL/6 mice

J Zhejiang Univ Sci B. 2016 Jun;17(6):437-46. doi: 10.1631/jzus.B1600074.

Abstract

Background: Myricetin is a naturally occurring antioxidant commonly found in various plants. However, little information is available with respect to its direct anti-obesity effects.

Objective: This study was undertaken to investigate the effect of myricetin on high-fat diet (HFD)-induced obesity in C57BL/6 mice.

Results: Administration of myricetin dramatically reduced the body weight of diet-induced obese mice compared with solely HFD-induced mice. Several parameters related to obesity including serum glucose, triglyceride, and cholesterol were significantly decreased in myricetin-treated mice. Moreover, obesity-associated oxidative stress (glutathione peroxidase (GPX) activity, total antioxidant capacity (T-AOC), and malondialdehyde (MDA)) and inflammation (tumor necrosis factor-α (TNF-α)) were ameliorated in myricetin-treated mice. Further investigation revealed that the protective effect of myricetin against HFD-induced obesity in mice appeared to be partially mediated through the down-regulation of mRNA expression of adipogenic transcription factors peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer-binding protein α (C/EBPα), and lipogenic transcription factor sterol regulatory element-binding protein 1c (SREBP-1c).

Conclusions: Consumption of myricetin may help to prevent obesity and obesity-related metabolic complications.

Keywords: Adipogenesis; Myricetin; Obesity; Oxidative stress.

MeSH terms

  • Adipose Tissue, White / drug effects
  • Adipose Tissue, White / metabolism
  • Animals
  • Diet, High-Fat
  • Flavonoids / pharmacology*
  • Intra-Abdominal Fat / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity / prevention & control*
  • Oxidative Stress / drug effects*
  • Protective Agents / pharmacology
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Flavonoids
  • Protective Agents
  • Tumor Necrosis Factor-alpha
  • myricetin